Aytu Biopharma Inc (NASDAQ:AYTU)
| 2.46 Delayed Data As of Dec 08 |  +0.04 / +1.65%Today’s Change | 1.38 Today|||52-Week Range 4.88 | -34.92% Year-to-Date |
Latest AYTU News | Press Releases
No recent news for Aytu Biopharma Inc.
Today’s Trading
| Previous close | 2.42 |
| Today’s open | 2.40 |
| Day’s range | 2.40 - 2.48 |
| Volume | 876 |
| Average volume (3 months) | 124,917 |
| Market cap | $13.5M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +93.19% |
| Earnings growth (this year) | +84.74% |
| Earnings growth (next 5 years) | +69.30% |
| Revenue growth (last year) | +11.10% |
| P/E ratio | NM |
| Price/Sales | 0.05 |
| Price/Book | 0.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNPXGenprex Inc | +0.00 | +0.87% |
| LPCNLipocine Inc | 0.00 | 0.00% |
| NNVCNanoViricides Inc | +0.02 | +2.16% |
| EIGREiger BioPharmaceuti... | -0.02 | -5.97% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | February 8, 2024 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $107.4M |
| Annual profit (last year) | -$17.1M |
| Net profit margin | -15.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Englewood, Colorado |
Forecasts
